Antipsychotics are widely used for the management of behavioural problems in people with learning disability, despite concerns about the lack of a good evidence base for this practice (see Cochrane review) The researchers in this study set out to audit clinical practice of prescribing anti-psychotics against standards of good practice. The authors collected data from [read the full story…]
Anti-psychotic medications comprise between 30–50% of all psychotropics prescribed for people with learning disabilities as reported in this WELD post: This study set out to explore metabolic syndrome (a group of risk factors that occur together and increase the risk for coronary artery disease, stroke and type 2 diabetes in people with learning disabilities who [read the full story…]
This audit of clinical practice in a mental health service for people with learning disabilities looked at the current approach to people with learning disabilities and psychotic disorders. The researchers looked at clinical practice with 910 people who were patients of the learning disability psychiatrists in Buckinghamshire. The current approach to clinical practice in the [read the full story…]
This article reports the findings of an audit carried out in Surrey to look at pain recognition and management with people with learning disabilities. The authors looked at what people with learning disabilities understood and experienced when they had pain, compared to what was reported as good practice in the literature. The authors found that [read the full story…]
